7 Dividend Stocks That Pay Me More Than $500 Per Month
https://www.fool.com/investing/2024/02/03/7-dividend-stocks-that-pay-me-more-than-500-per-mo/?source=iedfolrf0000001
Feb 03, 2024 - These stocks pay safe, reliable, and growing dividends.
0
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy
https://www.fool.com/investing/2024/02/11/these-17-words-from-abbvies-ceo-explain-why-the-st/?source=iedfolrf0000001
Feb 11, 2024 - The drugmaker is handling its biggest obstacle yet relatively well.
0
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
https://www.fool.com/investing/2023/12/12/abbvie-just-followed-pfizers-big-move-heres-what/?source=iedfolrf0000001
Dec 12, 2023 - It's making a major acquisition to beef up a key area of its pipeline.
0
2 Biotech Stocks You Can Buy and Hold for the Next Decade
https://www.fool.com/investing/2024/01/02/2-biotech-stocks-you-can-buy-and-hold-for-the-next/?source=iedfolrf0000001
Jan 02, 2024 - The types of innovative drugs these companies develop are always in high demand.
0
1 Concerning Trend for AbbVie Investors to Keep an Eye On
https://www.fool.com/investing/2024/01/03/1-concerning-trend-for-abbvie-investors-to-keep-an/?source=iedfolrf0000001
Jan 03, 2024 - Is AbbVie a good stock for dividend investors to own?
0
2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now
https://www.fool.com/investing/2024/01/28/2-high-yield-healthcare-stocks-to-buy-with-both-ha/?source=iedfolrf0000001
Jan 28, 2024 - All three of these stocks offer attractive dividend yields, but one looks risky.
0
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/02/02/abbvie-abbv-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 02, 2024 - ABBV earnings call for the period ending December 31, 2023.
0
2 Magnificent Dividend Growth Stocks to Load Up On Right Now
https://www.fool.com/investing/2024/02/06/2-magnificent-dividend-growth-stocks-to-load-up-on/?source=iedfolrf0000001
Feb 06, 2024 - These two dividend-growth stocks are fantastic buys.
0
3 Magnificent Growth Stocks to Buy Right Now
https://www.fool.com/investing/2024/02/19/3-magnificent-growth-stocks-to-buy-right-now/?source=iedfolrf0000001
Feb 19, 2024 - These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.
0
The AI Race Gets Litigious
https://www.fool.com/investing/2024/03/09/the-ai-race-gets-litigious/?source=iedfolrf0000001
Mar 09, 2024 - We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.
0
Page 1>